Perbedaan Metro Healthcare Indonesia Tbk. dan Brigit Biofarmaka Teknologi Tbk.: Metro Healthcare Indonesia Tbk. diperdagangkan di Rp428 (kapitalisasi pasar 14,23 T, volume 24 jam 346,3 rb), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp246 (kapitalisasi pasar 167,37 M, volume 24 jam 71 rb). Perbedaan utamanya: Metro Healthcare Indonesia Tbk. jauh lebih besar — sekitar 85× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Metro Healthcare Indonesia Tbk. lebih aktif diperdagangkan (346,3 rb vs 71 rb). Mana yang lebih baik tergantung tujuan investasimu.
| CARE | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 14,23 T | 167,37 M |
Volume | 346,3 rb | 71 rb |
Lot | 3,46 rb | 710 |
Perputaran | 147,93 jt | 17,51 jt |
Harga Rata-rata | 427,18 | 246,63 |
Nilai Transaksi | 147,93 jt | 17,51 jt |
Harga Ekuilibrium Indikatif | 428 | 246 |
Volume Ekuilibrium Indikatif | 10 | 1 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Metro Healthcare Indonesia Tbk (the “Company”) was established under the name PT Aruna Anjaya Perkasa, based on Notarial Deed No. 67 dated October 07, 2015 of Humberg Lie, S.H., S.E., M.Kn notary in Jakarta. The Company started its commercial operations in 2016 .
Selengkapnya di halaman CARE →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →